2 Undervalued Healthcare Stocks to Buy With $1,000
Cencora (NYSE: COR) and Stevanato Group (NYSE: STVN) have faced double-digit and mid-single-digit share price declines, respectively, so far in 2026, despite reporting steady earnings growth. While Cencora leverages a dominant position in the U.S. pharmaceutical supply chain to expand high-margin specialty services, Stevanato Group is capitalizing on the global surge in GLP-1 weight-loss and … Read more